4-ACETOXYTHORECTIDAEOLIDE_A
Compound with spectra: 1 NMR
| SpectraBase Compound ID | BWNFjgYlPYG |
|---|---|
| InChI | InChI=1S/C27H38O5/c1-18(10-13-23-20(3)12-15-25(29)27(23,5)6)8-7-9-19(2)11-14-24(32-21(4)28)22-16-26(30)31-17-22/h8,11,16,24H,7,9-10,12-15,17H2,1-6H3/b18-8+,19-11+/t24-/m1/s1 |
| InChIKey | AEZAGVMKPMJSBP-XFAJUAHPSA-N |
| Mol Weight | 442.6 g/mol |
| Molecular Formula | C27H38O5 |
| Exact Mass | 442.271924 g/mol |
| Enantiomer InChIKey | AEZAGVMKPMJSBP-NQTKHLAZSA-N |
| Racemate InChIKey | AEZAGVMKPMJSBP-SJSYCUIQSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2-{4'-[(5''-Oxo-2'',6'',6''-trimethylcyclohex-1''-enyl)-3'-oxo-2'-methylbut-2'-en-1'-yl]-2,3-dihydropyran-4-one
Monoprotected seco-Manoalide {4-[[(3E,7E)-10-(2,6,6-Trimethylcyclohex-1-en-1-yl]-8-methyl-4-formyl-1-hydroxydeca-3,7-dien-1-yl]-5-[2-(trimethylsilyl)eth-1-oxy]furan-2(5H)-one}
LYCIFERIN_D;3-BENZOYL-6-ACETYLJUNIFEROL
Methyl 4,8-dimethyl-1-(4'-methyl-3'-oxopentyl)-11-oxocycloundeca-3,7-diene-1-carboxylate
TASNEMOXIDE-B
(3E)-2-TERT.-BUTYL-1-METHYL-3-[(2E)-2-METHYL-4-(2,6,6-TRIMETHYLCYCLOHEX-1-EN-1-YL)-BUT-2-ENYLIDENE]-CYCLOBUT-1-EN-4-CARBALDEHYDE
CRASSUMOL-C;[2S*,7S*,8S*,(3E),(11E)]-7-ACETOXY-8-HYDROXY-CEMBRA-3,11-DIEN
(8aR)-5,8a-Dimethyl-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione
(4E)-6-[(TERT.-BUTYLDIMETHYLSILYL)-OXY]-4-METHYL-1-[(1E)-1-METHYL-3-(2,6,6-TRIMETHYLCYCLOHEX-1-EN-1-YL)-PROP-1-EN-1-YL]-HEX-4-EN-2-YNYL-BENZOATE
Cespitularin C
| Title | Journal or Book | Year |
|---|---|---|
| Structures and Potential Antitumor Activity of Sesterterpenes from the Marine Sponge Hyrtios communis | Journal of Natural Products | 2013 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.